Related Experiment Video
Updated: Oct 7, 2025

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
Interrelationship between 2019-nCov receptor DPP4 and diabetes mellitus targets based on protein interaction network
Qian Gao1, Wenjun Zhang2, Tingting Li2
1Affiliated Hospital of Shaoxing University of Endocrine and Metabolism Department, Zhejiang, China. 420293991@qq.com.
Abstract:
Patients with diabetes are more likely to be infected with Coronavirus disease 2019 (COVID-19), and the risk of death is significantly higher than ordinary patients. Dipeptidyl peptidase-4 (DPP4) is one of the functional receptor of human coronavirus. Exploring the relationship between diabetes mellitus targets and DPP4 is particularly important for the management of patients with diabetes and COVID-19. We intend to study the protein interaction through the protein interaction network in order to find a new clue for the management of patients with diabetes with COVID-19. Diabetes mellitus targets were obtained from GeneCards database. Targets with a relevance score exceeding 20 were included, and DPP4 protein was added manually. The initial protein interaction network was obtained through String. The targets directly related to DPP4 were selected as the final analysis targets. Importing them into String again to obtain the protein interaction network. Module identification, gene ontology (GO) analysis and Kyoto encyclopedia of genes and genomes (KEGG) pathway analysis were carried out respectively. The impact of DPP4 on the whole network was analyzed by scoring the module where it located. 43 DPP4-related proteins were finally selected from the diabetes mellitus targets and three functional modules were found by the cluster analysis. Module 1 was involved in insulin secretion and glucagon signaling pathway, module 2 and module 3 were involved in signaling receptor binding. The scoring results showed that LEP and apoB in module 1 were the highest, and the scores of INS, IL6 and ALB of cross module associated proteins of module 1 were the highest. DPP4 is widely associated with key proteins in diabetes mellitus. COVID-19 may affect DPP4 in patients with diabetes mellitus, leading to high mortality of diabetes mellitus combined with COVID-19. DPP4 inhibitors and IL-6 antagonists can be considered to reduce the effect of COVID-19 infection on patients with diabetes.
Insights
Patients with diabetes face higher COVID-19 risks. This study explores how Dipeptidyl peptidase-4 (DPP4), a coronavirus receptor, interacts with diabetes targets, suggesting DPP4 inhibitors and IL-6 antagonists may help manage severe cases.
Area of Science:
- Biochemistry
- Virology
- Endocrinology
Background:
- Diabetes mellitus patients exhibit increased susceptibility and mortality rates from Coronavirus disease 2019 (COVID-19).
- Dipeptidyl peptidase-4 (DPP4) serves as a functional receptor for human coronaviruses, highlighting a potential link between diabetes and viral infection severity.
Purpose of the Study:
- To investigate the intricate relationship between diabetes mellitus targets and DPP4.
- To identify novel therapeutic strategies for managing patients with comorbid diabetes and COVID-19 through protein interaction network analysis.
Main Methods:
- Collected diabetes mellitus targets from the GeneCards database, including DPP4.
- Constructed and analyzed protein interaction networks using the String database.
- Performed module identification, Gene Ontology (GO), and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses.
Main Results:
- Identified 43 DPP4-related proteins from diabetes targets, revealing three distinct functional modules.
- Module 1 is associated with insulin secretion and the glucagon signaling pathway; Modules 2 and 3 are linked to signaling receptor binding.
- LEP, apoB, INS, IL6, and ALB emerged as key proteins with high scores, indicating significant interactions within the network.
Conclusions:
- Dipeptidyl peptidase-4 (DPP4) is extensively interconnected with critical proteins in diabetes mellitus.
- COVID-19's impact on DPP4 in diabetic patients may contribute to elevated mortality.
- DPP4 inhibitors and IL-6 antagonists represent potential therapeutic avenues to mitigate COVID-19's adverse effects in diabetic individuals.
More Related Videos
08:47Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy
Published on: December 7, 2017
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
Related Concept Videos
Protein-protein Interfaces
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Insulin: The Receptor and Signaling Pathways
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Dipeptidyl Peptidase 4 Inhibitors
Psychoneuroimmunology: Diabetes and Cancer